Suppr超能文献

相似文献

1
Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A.
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2735-40. doi: 10.1073/pnas.1013987108. Epub 2011 Jan 31.
2
Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban.
Science. 2003 Feb 28;299(5611):1410-3. doi: 10.1126/science.1081578.
3
Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy.
J Biol Chem. 2012 May 11;287(20):16521-9. doi: 10.1074/jbc.M112.360859. Epub 2012 Mar 16.
4
Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition.
Circulation. 2009 Jan 27;119(3):436-44. doi: 10.1161/CIRCULATIONAHA.108.783506. Epub 2009 Jan 12.
5
A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia.
Cardiovasc Res. 2015 Jul 1;107(1):164-74. doi: 10.1093/cvr/cvv127. Epub 2015 Apr 7.
6
Effects of the Arg9Cys and Arg25Cys mutations on phospholamban's conformational equilibrium in membrane bilayers.
Biochim Biophys Acta Biomembr. 2018 Jun;1860(6):1335-1341. doi: 10.1016/j.bbamem.2018.02.030. Epub 2018 Mar 2.
7
Acute inotropic and lusitropic effects of cardiomyopathic R9C mutation of phospholamban.
J Biol Chem. 2015 Mar 13;290(11):7130-40. doi: 10.1074/jbc.M114.630319. Epub 2015 Jan 15.
8
Phospholamban pentamers attenuate PKA-dependent phosphorylation of monomers.
J Mol Cell Cardiol. 2015 Mar;80:90-7. doi: 10.1016/j.yjmcc.2014.12.020. Epub 2015 Jan 3.
9
10
Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
Glycobiology. 2010 Oct;20(10):1217-26. doi: 10.1093/glycob/cwq071. Epub 2010 May 18.

引用本文的文献

1
Genetic landscape of phospholamban cardiomyopathies.
Front Cell Dev Biol. 2025 Jun 10;13:1626242. doi: 10.3389/fcell.2025.1626242. eCollection 2025.
2
Calcium handling remodeling in dilated cardiomyopathy: From molecular mechanisms to targeted therapies.
Channels (Austin). 2025 Dec;19(1):2519545. doi: 10.1080/19336950.2025.2519545. Epub 2025 Jun 16.
3
RiceReceptor: The Cell-Surface and Intracellular Immune Receptors of the Genus.
Genes (Basel). 2025 May 18;16(5):597. doi: 10.3390/genes16050597.
4
Dilated cardiomyopathy variant R14del increases phospholamban pentamer stability, blunting dynamic regulation of calcium.
J Biol Chem. 2025 Feb;301(2):108118. doi: 10.1016/j.jbc.2024.108118. Epub 2024 Dec 21.
5
Reassessing the Mechanisms of PLN-R14del Cardiomyopathy: From Calcium Dysregulation to S/ER Malformation.
JACC Basic Transl Sci. 2024 Apr 17;9(8):1041-1052. doi: 10.1016/j.jacbts.2024.02.017. eCollection 2024 Aug.
6
Activation of IPR in atrial cardiomyocytes leads to generation of cytosolic cAMP.
Am J Physiol Heart Circ Physiol. 2024 Oct 1;327(4):H830-H846. doi: 10.1152/ajpheart.00152.2024. Epub 2024 Aug 2.
7
Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition.
Biochim Biophys Acta Biomembr. 2024 Oct;1866(7):184370. doi: 10.1016/j.bbamem.2024.184370. Epub 2024 Jul 8.
8
Phosphorylation of phospholamban promotes SERCA2a activation by dwarf open reading frame (DWORF).
Cell Calcium. 2024 Jul;121:102910. doi: 10.1016/j.ceca.2024.102910. Epub 2024 May 24.
9
Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation.
Cardiovasc Res. 2023 Jul 4;119(7):1568-1582. doi: 10.1093/cvr/cvad037.
10
Micropeptide hetero-oligomerization adds complexity to the calcium pump regulatory network.
Biophys J. 2023 Jan 17;122(2):301-309. doi: 10.1016/j.bpj.2022.12.014. Epub 2022 Dec 15.

本文引用的文献

1
[37] Reaction of protein sulfhydryl groups with Ellman's reagent.
Methods Enzymol. 1972;25:457-64. doi: 10.1016/S0076-6879(72)25041-8.
2
Phosphorylation and mutation of phospholamban alter physical interactions with the sarcoplasmic reticulum calcium pump.
J Mol Biol. 2011 Jan 21;405(3):707-23. doi: 10.1016/j.jmb.2010.11.014. Epub 2010 Nov 23.
3
Dilated cardiomyopathy.
Lancet. 2010 Feb 27;375(9716):752-62. doi: 10.1016/S0140-6736(09)62023-7.
4
The genetics of dilated cardiomyopathy.
Curr Opin Cardiol. 2010 May;25(3):198-204. doi: 10.1097/HCO.0b013e328337ba52.
5
Rescue of familial cardiomyopathies by modifications at the level of sarcomere and Ca2+ fluxes.
J Mol Cell Cardiol. 2010 May;48(5):834-42. doi: 10.1016/j.yjmcc.2010.01.003. Epub 2010 Jan 15.
6
Structure and topology of monomeric phospholamban in lipid membranes determined by a hybrid solution and solid-state NMR approach.
Proc Natl Acad Sci U S A. 2009 Jun 23;106(25):10165-70. doi: 10.1073/pnas.0904290106. Epub 2009 Jun 9.
7
Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition.
Circulation. 2009 Jan 27;119(3):436-44. doi: 10.1161/CIRCULATIONAHA.108.783506. Epub 2009 Jan 12.
9
Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex.
J Biol Chem. 2008 Oct 24;283(43):28996-9003. doi: 10.1074/jbc.M804782200. Epub 2008 Aug 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验